[HTML][HTML] Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience
E Pfaff, A El Damaty, GP Balasubramanian… - European Journal of …, 2019 - Elsevier
Purpose Diffuse intrinsic pontine glioma (DIPG) is a highly aggressive paediatric brain
tumour with fatal outcome. The Individualised Therapy For Relapsed Malignancies In …
tumour with fatal outcome. The Individualised Therapy For Relapsed Malignancies In …
[HTML][HTML] Epigenetic regulation of TGF-β-induced EMT by JMJD3/KDM6B histone H3K27 demethylase
SH Lee, O Kim, HJ Kim, C Hwangbo, JH Lee - Oncogenesis, 2021 - nature.com
Transforming growth factor-β (TGF-β) signaling pathways are well-recognized for their role
in proliferation and epithelial–mesenchymal transition (EMT) of cancer cells, but much less …
in proliferation and epithelial–mesenchymal transition (EMT) of cancer cells, but much less …
Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling
B Sadikovic, M Yoshimoto… - Human molecular …, 2009 - academic.oup.com
Altered gene expression in tumors can be caused by copy number alterations to DNA or
mutation affecting coding or regulatory regions of genes. However, epigenetic events may …
mutation affecting coding or regulatory regions of genes. However, epigenetic events may …
Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells
T Murata, Y Kondo, A Sugimoto, D Kawashima… - Journal of …, 2012 - Am Soc Microbiol
ABSTRACT The Epstein-Barr virus (EBV) predominantly establishes latent infection in B
cells, and the reactivation of the virus from latency is dependent on the expression of the …
cells, and the reactivation of the virus from latency is dependent on the expression of the …
A covalently bound inhibitor triggers EZH 2 degradation through CHIP‐mediated ubiquitination
X Wang, W Cao, J Zhang, M Yan, Q Xu, X Wu… - The EMBO …, 2017 - embopress.org
Enhancer of zeste homolog 2 (EZH 2) has been characterized as a critical oncogene and a
promising drug target in human malignant tumors. The current EZH 2 inhibitors strongly …
promising drug target in human malignant tumors. The current EZH 2 inhibitors strongly …
Tumorigenic cell reprogramming and cancer plasticity: interplay between signaling, microenvironment, and epigenetics
V Poli, L Fagnocchi, A Zippo - Stem cells international, 2018 - Wiley Online Library
Accumulating evidences indicate that many tumors rely on subpopulations of cancer stem
cells (CSCs) with the ability to propagate malignant clones indefinitely and to produce an …
cells (CSCs) with the ability to propagate malignant clones indefinitely and to produce an …
RNA-Seq reveals common and unique PXR-and CAR-target gene signatures in the mouse liver transcriptome
JY Cui, CD Klaassen - Biochimica et Biophysica Acta (BBA)-Gene …, 2016 - Elsevier
The pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are well-known
xenobiotic-sensing nuclear receptors with overlapping functions. However, there lacks a …
xenobiotic-sensing nuclear receptors with overlapping functions. However, there lacks a …
Promoter‐specific transcriptional interference and c‐myc gene silencing by siRNAs in human cells
S Napoli, C Pastori, M Magistri, GM Carbone… - The EMBO …, 2009 - embopress.org
Small interfering RNAs (siRNAs) directed to gene promoters can silence genes at the
transcriptional level. siRNA‐directed transcriptional silencing (RdTS) was first described in …
transcriptional level. siRNA‐directed transcriptional silencing (RdTS) was first described in …
Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma
Y Goto, K Shinjo, Y Kondo, L Shen, M Toyota, H Suzuki… - Cancer research, 2009 - AACR
Malignant pleural mesothelioma (MPM) is a fatal thoracic malignancy, the epigenetics of
which are poorly defined. We performed high-throughput methylation analysis covering …
which are poorly defined. We performed high-throughput methylation analysis covering …
Epigenetic changes in the myelodysplastic syndrome
JP Issa - Hematology/Oncology Clinics, 2010 - hemonc.theclinics.com
The myelodysplastic syndromes (MDSs) are a group of diverse and heterogeneous
syndromes characterized by clonal proliferation, bone marrow failure, and an increased risk …
syndromes characterized by clonal proliferation, bone marrow failure, and an increased risk …